| 000 | 01735 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250518101556.0 | ||
| 264 | 0 | _c20200806 | |
| 008 | 202008s 0 0 eng d | ||
| 022 | _a1943-572X | ||
| 024 | 7 |
_a10.1177/0003489420918280 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBen Elhadj, Mariem | |
| 245 | 0 | 0 |
_aPrevalence and Prognostic Value of HPV among Tunisian Patients with Laryngeal Cancer and Relationship between DNA HPV and p16, IGF-1R, Survivin, p53 Expressions. _h[electronic resource] |
| 260 |
_bThe Annals of otology, rhinology, and laryngology _cSep 2020 |
||
| 300 |
_a863-871 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aCyclin-Dependent Kinase Inhibitor p16 _xanalysis |
| 650 | 0 | 4 |
_aDNA, Viral _xanalysis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLaryngeal Neoplasms _xchemistry |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPapillomaviridae _xgenetics |
| 650 | 0 | 4 |
_aPapillomavirus Infections _xcomplications |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aReceptor, IGF Type 1 _xanalysis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aSurvivin _xanalysis |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xanalysis |
| 650 | 0 | 4 | _aTunisia |
| 700 | 1 | _aFourati, Asma | |
| 700 | 1 | _aEl Amine, Olfa | |
| 700 | 1 | _aGoucha, Aida | |
| 700 | 1 | _aEl May, Ahmed | |
| 700 | 1 | _aEl May, Michèle-Veronique | |
| 700 | 1 | _aMokni Baizig, Nehla | |
| 773 | 0 |
_tThe Annals of otology, rhinology, and laryngology _gvol. 129 _gno. 9 _gp. 863-871 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/0003489420918280 _zAvailable from publisher's website |
| 999 |
_c30929983 _d30929983 |
||